Independent Validation of the Japanese Version of the EORTC QLQ-C15-PAL for Patients With Advanced Cancer

Wada, Makoto; Morita, Tatsuya; Ishida, M.; Onishi, Hideki; Sasaki, Yasutsuna; Narabayashi, Masaru; Wada, Tomomi; Matsubara, Mei; Takigawa, Chizuko; Shinjo, Takuya; Suga, Akihiko; Inoue, Satoshi; Ikenaga, Masakazu; Kohara, Hiroyuki; Tsuneto, Satoru; Shima, Yasuo

doi:10.1016/j.jpainsymman.2014.11.299

Cited by 13 publications

(25 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The global QOL item is rated from 1 (very poor) to 7 (excellent), and the others are rated from 1 (not at all) to 4 (very much). The reliability and validity of the Japanese version have been confirmed [44].…”

Section: Support Team Assessment Schedule (Stas)mentioning

confidence: 77%

The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02)

et al. 2020

View full text Add to dashboard Cite

Background Although rehabilitation is recommended for terminal cancer patients, the specific components and methods of such programs are poorly documented. No studies to date have examined the effectiveness of rehabilitation for terminal cancer patients. This study aims to evaluate the efficacy of a new intervention for rehabilitation therapists, using the Op-reha Guide (Guide to Optimal and Patient-Centred Rehabilitation Practice for Patients in Palliative Care Units [PCUs]) in rehabilitation practice. This guide consists of recommended actions and attitudes for rehabilitation therapists and aims to optimise therapists’ actions according to the patient’s needs and condition. It shares goals with terminal cancer patients to maintain their activities of daily living (ADL). Methods This study uses a multicentre, prospective, randomised controlled trial (RCT) design with two parallel groups in PCUs where specialised rehabilitation will be routinely performed for terminal cancer patients by rehabilitation therapists. Participants will be randomised (1:1) to intervention (the Op-reha Guide) and control groups (usual rehabilitation). We will then conduct an observational study in PCUs that do not perform specialised rehabilitation for terminal cancer patients; this will be considered the usual care group, and the efficacy of usual rehabilitation will be quantitatively evaluated. Inclusion criteria are hospitalisation in PCU, European Cooperative Oncology Group Performance Status of 2 or 3, and clinical estimation of life expectancy of 3 weeks or more. Patients with severe symptom burden will be excluded. We hypothesise that the Op-reha Guide will be more effective in maintaining the ADL of terminal cancer patients hospitalised in PCUs than usual rehabilitation. The primary endpoint is defined as the change in (total) modified Barthel Index from baseline to Day 22. Quality of life will be a secondary endpoint. In total, 135 patients will be recruited from 16 Japanese sites between July 2019 and December 2021. Discussion This will be the first trial to evaluate the efficacy of specialised rehabilitation for terminal cancer patients hospitalised in PCUs, and will contribute to the evidence on the efficacy of implementing rehabilitation for terminal cancer patients. Trial registration UMIN-CTR, UMIN000037298 R000042525 (date of registration 7 July 2019).

show abstract

Section: Support Team Assessment Schedule (Stas)mentioning

confidence: 77%

The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02)

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Compliance of outpatients with diary completion was checked via telephone contact. The QOL data were recorded by the patients before the study and on day 7 after the study period using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ‐C15‐PAL questionnaire .…”

Section: Subjects Materials and Methodsmentioning

confidence: 99%

“…EORTC QLQ‐C15‐PAL is a QOL questionnaire designed for use in patients receiving palliative care . This questionnaire includes two functional subscales (emotional and physical), seven symptom subscales (e.g., nausea/vomiting, pain), and an overall QOL question.…”

Section: Subjects Materials and Methodsmentioning

confidence: 99%

Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial

et al. 2017

Self Cite

View full text Add to dashboard Cite

Prophylactic prochlorperazine seems to be ineffective in preventing opioid-induced nausea and vomiting (OINV) and may cause adverse events such as somnolence. Routine use of prophylactic prochlorperazine at the initiation of treatment with opioids is not recommended. Further research is needed to evaluate whether other antiemetics would be effective in preventing OINV in specific patient populations.

show abstract

“…Numerous studies of such assessment methods have been conducted 5,6 , such as the 1993 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core Module 30 EORTC QLQ-C30 7 . In Japan, studies have been performed using the Japanese versions of the Brief Pain Inventory BPI-J 8 and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core Module 15-Palliative Care EORTC QLQ-C15-PAL 9 . These measures have also been used to assess the effects of different pain intensity levels on patient pain management satisfaction and daily living 10 .…”

Section: Introductionmentioning

confidence: 99%

Integrating Cancer Patients’ Satisfaction with Rescue Medication in Pain Assessments

Wada

Handa

Yamamoto

et al. 2020

Showa Univ J Med Sci

View full text Add to dashboard Cite

A patient s pain intensity rating alone is insuf cient grounds for determining the pain medication and dosage to administer daily. This study aimed to investigate whether a convenient assessment method could be developed that would reflect the effectiveness of an opioid analgesic on cancer patients pain management. We investigated pain intensity worst, least, average, current and the effectiveness of the opioid rescue medication in terms of patient satisfaction. This study used Spearman s rank correlation coefficients to evaluate the relationships between patient satisfaction with rescue medication and both pain intensity and the medication s perceived effectiveness. Data from 60 participants with a mean age of 60.5 11.4 years range : 31-79 years were analyzed. Thirty-eight 63.3% participants were male, and 22 36.7% were female. The correlations found between rescue medication satisfaction and both the worst numerical rating scale NRS rating r 0.15, P 0.16 and the average NRS rating r 0.13, P 0.13 were not statistically signi cant. A signi cant positive correlation was observed between rescue medication satisfaction and the medication s perceived effectiveness r 0.79, P 0.0001. Patient satisfaction with their rescue medication can be routinely assessed without imposing a signi cant burden on the patient. A new assessment method incorporating rescue medication satisfaction and pain intensity measures could allow routine pain assessments to re ect both pain intensity and the effectiveness of opioid analgesics. This new assessment method is potentially preferable to selfreported pain intensity and can identify patients for whom treatment is a priority. It also facilitates rapid dose adjustments and reduces the side effects of overdose due to unnecessary increases in opioid analgesics..

show abstract

Independent Validation of the Japanese Version of the EORTC QLQ-C15-PAL for Patients With Advanced Cancer

Abstract: The Japanese version of EORTC QLQ-C15-PAL has sufficient validity, acceptable reliability, and feasibility for patients with advanced cancer.

Cited by 13 publications

References 19 publications

The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02)

The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02)

Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial

Integrating Cancer Patients’ Satisfaction with Rescue Medication in Pain Assessments

Contact Info

Product

Resources

About